U.S. markets closed
  • S&P 500

    4,173.85
    +61.35 (+1.49%)
     
  • Dow 30

    34,382.13
    +360.68 (+1.06%)
     
  • Nasdaq

    13,429.98
    +304.99 (+2.32%)
     
  • Russell 2000

    2,224.63
    +53.68 (+2.47%)
     
  • Crude Oil

    65.51
    +1.69 (+2.65%)
     
  • Gold

    1,844.00
    +20.00 (+1.10%)
     
  • Silver

    27.50
    +0.46 (+1.69%)
     
  • EUR/USD

    1.2146
    +0.0062 (+0.51%)
     
  • 10-Yr Bond

    1.6350
    -0.0330 (-1.98%)
     
  • GBP/USD

    1.4102
    +0.0050 (+0.36%)
     
  • USD/JPY

    109.3470
    -0.0870 (-0.08%)
     
  • BTC-USD

    46,965.51
    -2,939.92 (-5.89%)
     
  • CMC Crypto 200

    1,398.33
    +39.77 (+2.93%)
     
  • FTSE 100

    7,043.61
    +80.28 (+1.15%)
     
  • Nikkei 225

    28,084.47
    +636.46 (+2.32%)
     

Integer Holdings: Q4 Earnings Insights

  • Oops!
    Something went wrong.
    Please try again later.
Benzinga Insights
·1 min read
  • Oops!
    Something went wrong.
    Please try again later.

 

Shares of Integer Holdings (NYSE:ITGR) rose 0.3% in pre-market trading after the company reported Q4 results.

Quarterly Results

Earnings per share decreased 43.20% over the past year to $0.71, which beat the estimate of $0.61.

Revenue of $268,959,000 declined by 17.41% year over year, which beat the estimate of $263,770,000.

Guidance

The upcoming fiscal year's EPS expected to be between $3.40 and $3.90.

The upcoming fiscal year's revenue expected to be between $1,160,000,000 and $1,200,000,000.

Conference Call Details

Date: Feb 18, 2021

View more earnings on ITGR

Time: 09:00 AM

ET Webcast URL: https://event.on24.com/eventRegistration/EventLobbyServlet?target=reg20.jsp&referrer=https%3A%2F%2Fwww.google.com%2F&eventid=2947634&sessionid=1&key=B4477EF08B4FC702A670232AC035906B&regTag=&V2=false&sourcepage=register

Recent Stock Performance

Company's 52-week high was at $99.95

52-week low: $46.01

Price action over last quarter: Up 31.48%

Company Description

Integer Holdings is a manufacturer of medical device components used by original equipment manufacturers in the medical industry. The company also develops batteries used in nonmedical applications in the energy, military, and environmental markets. The firm organizes itself into two business segments based on the product type: medical and nonmedical. The medical segment uses the firm's technologies to produce components and finished medical devices, and it generates the vast majority of revenue. The company earns more than half of its revenue in United States.

See more from Benzinga

© 2021 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.